Financhill
Buy
72

GHM Quote, Financials, Valuation and Earnings

Last price:
$70.71
Seasonality move :
10.5%
Day range:
$68.58 - $72.09
52-week range:
$24.78 - $72.09
Dividend yield:
0%
P/E ratio:
57.27x
P/S ratio:
3.43x
P/B ratio:
6.08x
Volume:
117.5K
Avg. volume:
99.7K
1-year change:
60.99%
Market cap:
$775.9M
Revenue:
$209.9M
EPS (TTM):
$1.23

Earnings Data

Next earnings date for GHM
Feb 05
2026
Most recent earnings per share
$0.28
Missed by $0.05
(Nov 7/2025)
Consensus Estimate
$0.33
(Nov 7/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GHM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/05/2026 Q4 $52.4M -- -- $0.18 --
11/07/2025 Q3 $57.6M $66M $0.28 $0.33 -$0.05
08/05/2025 Q2 $56.6M $55.5M $0.42 $0.23 $0.18
06/09/2025 Q1 $55.7M $59.3M $0.40 $0.19 $0.21
02/07/2025 Q4 $49.5M $47M $0.14 $0.08 $0.07
11/08/2024 Q3 $49.7M $53.6M $0.30 $0.13 $0.17
08/07/2024 Q2 $50.1M $50M $0.27 $0.18 $0.09
06/07/2024 Q1 $44.5M $49.1M $0.12 -- --
02/05/2024 Q4 $38.9M $43.8M $0.02 -- --
11/06/2023 Q3 -- $45.1M $0.04 -- --
08/07/2023 Q2 -- $47.6M $0.25 -- --
06/08/2023 Q1 -- $43M -$0.05 -- --
02/06/2023 Q4 -- $39.9M $0.03 -- --
11/07/2022 Q3 -- $38.1M -$0.02 -- --
07/29/2022 Q2 -- $36.1M $0.06 -- --
06/08/2022 Q1 -- $39.7M -$0.13 -- --
02/07/2022 Q4 -- $28.8M -$0.35 -- --
10/27/2021 Q3 -- $34.1M -$0.05 -- --
08/10/2021 Q2 -- $20.2M -$0.31 -- --
06/01/2021 Q1 -- $25.7M $0.04 -- --
01/28/2021 Q4 -- $27.2M $0.11 -- --
10/28/2020 Q3 -- $28M $0.28 -- --
07/30/2020 Q2 -- $16.7M -$0.18 -- --
06/10/2020 Q1 -- $23.1M $0.06 -- --
01/29/2020 Q4 -- $25.3M $0.00 -- --
10/30/2019 Q3 -- $21.6M $0.12 -- --
07/26/2019 Q2 -- $20.6M $0.01 -- --
05/30/2019 Q1 -- $23.6M -$0.46 -- --
01/30/2019 Q4 -- $17.2M $0.01 -- --
11/08/2018 Q3 -- $21.4M $0.19 -- --
08/03/2018 Q2 -- $29.6M $0.24 -- --
05/31/2018 Q1 -- $22.2M $0.09 -- --
02/01/2018 Q4 -- $17.3M -$1.19 -- --
10/25/2017 Q3 -- $17.2M $0.00 -- --
08/04/2017 Q2 -- $20.9M $0.10 -- --
06/01/2017 Q1 -- $25.6M $0.18 -- --
02/01/2017 Q4 -- $22.7M $0.19 -- --
11/01/2016 Q3 -- $21.1M $0.13 -- --
07/29/2016 Q2 -- $22.4M $0.01 -- --
05/25/2016 Q1 -- $22.3M $0.05 -- --
01/29/2016 Q4 -- $17.3M $0.13 -- --

Graham Corp. Earnings Questions

  • How Much did Graham Corp. Generate in Revenue Last Quarter?

    Graham Corp. reported $66M worth of top line sales in its most recent quarter.

  • Did Graham Corp. Beat Earnings Last Quarter?

    Graham Corp. announced earnings per share of $0.28 which represents a miss of analyst forecast a $0.33 per share.

  • Is Graham Corp. Profitable?

    Graham Corp. reported $13.9M that represents $1.25 per share over the last quarter.

  • What is the Analyst Consensus for Graham Corp. EPS Next Year?

    Graham Corp.'s earnings are forecast to grow from $1.11 per share to $1.00 per share next year representing an increase of 16.42%.

  • When is Graham Corp.'s Earnings Date?

    Graham Corp.'s next earnings date is February 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock